"I'm fine; I'm just waiting for my disease": The new and growing class of presymptomatic patients

Neurology

Volumn 77, Issue 6, 2011, Pages 522-523

  Kwon, Jennifer M ^a   Steiner, Robert D ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE ANTIBODY; ANTIBODY; GLYCOGEN; TETRASACCHARIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ATONIC COLON; CARDIOMYOPATHY; CAUSE OF DEATH; DISEASE COURSE; EARLY DIAGNOSIS; EDITORIAL; ENZYME REPLACEMENT; FOLLOW UP; GENETIC SCREENING; GLOBOID CELL LEUKODYSTROPHY; GLYCOGEN STORAGE DISEASE TYPE 2; HEALTH CARE COST; HEART FUNCTION; HUMAN; MOTOR PERFORMANCE; NEWBORN SCREENING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONSET AGE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SKELETAL MUSCLE; ADULT; CASE REPORT; FEMALE; INFANT; MALE; NEWBORN; NOTE; PSYCHOLOGICAL ASPECT;

ADULT; DISEASE PROGRESSION; EARLY DIAGNOSIS; ENZYME REPLACEMENT THERAPY; FEMALE; GENETIC TESTING; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING;

EID: 80053337571     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318228c15f     Document Type: Editorial

References (8)

1. Laloui K, Wary C, Carlier R-Y, Hogrel J-Y, Caillaud C, Laforêt P. Making diagnosis of Pompe disease at a presymptomatic stage: to treat or not to treat? Neurology 2011;77:594-595.
2. Kolata G. Tests detect Alzheimer's risks, but should patients be told? New York Times Dec. 18, 2010: A1.
3. Kemper AR, Hwu W-L, Lloyd-Puryear M, Kishnani PS. Newborn screening for Pompe disease: synthesis of the evidence and development of screening recommendations. Pediatrics 2007;120: e1327-e1334.
4. Steiner RD. Commentary on: "Newborn screening for Krabbe disease: the New York State model" and "The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: a report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York." Genet Med 2009;11:411-413.
5. 2006-2009 Annual reports of the New York State newborn screening program. Available at: http://www.wadsworth.org/newborn/annualrept/annsum.htm. Accessed March 11, 2011.
6. Timmermans S, Buchbinder M. Patients-in-waiting: living between sickness and health in the genomics era. J Health Soc Behav 2010;51:408-423.
7. de Filippi P, Ravaglia S, Bembi B, et al. The angiotensinconverting enzyme insertion/deletion polymorphism modifies the clinical outcome in patients with Pompe disease. Genet Med 2010;12:206-211.
8. Young SP, Zhang H, Corzo D, et al. Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker. Genet Med 2009;11:536-541.